Investegate |SkinBioTherapeutics Announcements | SkinBioTherapeutics: Enrolment for AxisBiotix-PsT study commences
· Targeting 200+ applicants, study will be monitored through a smart phone application · Study due to commence in February 2021 SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that AxisBiotix Limited, a wholly owned subsidiary of the Company, has commenced enrolment for its food supplement consumer study. Further to research exploring the relationship between the gut and the skin and the scientific evidence pointing to a link between gut dysfunction, stress-...
Source: investegate.co.uk